ERASCA, INC.
Ownership & governance
Executives 5Directors 8Avg age 60Avg tenure 6.2y
JL
Jonathan Lim
Chief Executive Officer
Age 54Since 2019-02-28Profile →
+12
Executives5
Board of directors8
JL
Jonathan Lim→
Chairman
Age 54Since 2018-09-30
JB
James Bristol→
Director/Board Member
Age 79Since 2018-05-31
AC
Alexander Casdin→
Director/Board Member
Age 58Since 2018-07-01
PM
Pratik Multani→
Director/Board Member
Age 59Since 2018-07-01
MV
Michael Varney→
Director/Board Member
Age 67Since 2020-12-17
JH
Julie Hambleton→
Director/Board Member
Age 68Since 2021-03-28
VS
Valerie Start→
Director/Board Member
Age 66Since 2019-05-31
JL
Jean Liu→
Director/Board Member
Age 57Since 2022-04-24
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Jonathan Lim | 10.4 % | 32,355,576 |
| Frazier Life Sciences Management LP | 7.935 % | 24,675,188 |
| T. Rowe Price Investment Management, Inc. | 6.836 % | 21,259,646 |
| BlackRock Advisors LLC | 5.77 % | 17,944,771 |
| Venrock Associates | 5.268 % | 16,382,812 |
Catalog · 2026-07-09
Registry officers13
| Name | Role | Since | Shares |
|---|---|---|---|
| Amy Grekowicz Parker | Chief Tech/Sci/R&D Officer | 2022-05-24 | - |
| David Chacko | Director of Finance/CFO | 2021-01-06 | - |
| Jonathan Lim | Chairman | 2018-09-30 | - |
| Jonathan Lim | Chief Executive Officer | 2019-02-28 | - |
| Les Brail | Chief Tech/Sci/R&D Officer | — | - |
| Shannon Morris | Chief Tech/Sci/R&D Officer | 2022-05-24 | - |
| Alexander Casdin | Director/Board Member | 2018-07-01 | - |
| James Bristol | Director/Board Member | 2018-05-31 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus noneMean target 24.11Range 20–33Analysts 9
20Mean 24.1133
- Strong buy 2
- Buy 5
- Hold 2
Broker actions40 of 55
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| B of A Securities | Maintained | Neutral | 20 | 2026-08-14 |
| Guggenheim | Maintained | Buy | 21 | 2026-08-13 |
| HC Wainwright & Co. | Maintained | Buy | 22 | 2026-08-12 |
| Morgan Stanley | Maintained | Equal-Weight | 21 | 2026-07-20 |
| B of A Securities | Maintained | Neutral | 18 | 2026-07-14 |
| B of A Securities | Upgrade | Neutral | 16 | 2026-06-04 |
| Mizuho | Maintained | Outperform | 26 | 2026-05-12 |
| Stifel | Maintained | Buy | 30 | 2026-04-27 |
| JP Morgan | Maintained | Overweight | 25 | 2026-03-18 |
| Guggenheim | Maintained | Buy | 20 | 2026-03-16 |
| Piper Sandler | Maintained | Overweight | 18 | 2026-03-13 |
| Mizuho | Maintained | Outperform | 19 | 2026-03-13 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.